Tuesday, September 22, 2020 9:21:31 AM
REASON:
#1. AW should have commercialized the initial product for the treatment of post-operative pain relating to eyelid surgery. That would have negated the need for dilutive financing. If done, today's OS would likely be in the millions, not tens of billions.
#2. Major deals were nixed by AW. Was he suffering from dementia, or did he never intend to sell the products? IDK, but I do know that AW killed some great relationships with former BIEL customers.
#3. The funds came from investors buying unregistered shares of BIEL, printed by AW, and granted to IBEX (KW). Not from the Whelan checking account.
4 The financing arrangement enjoyed by the Whelan's was designed largely for the Whelans. For their personal enrichment. It has fed their family for 20-years AND given them the potential to own nearly 2/3rds of our company. They've benefited from this loan program more than anyone else. It was not publically touted to the investment community. Rather, it was kept mainly under wraps and used by insiders.
HOW MUCH MONEY DID BORROWING FROM THE WHELAN FAMILY ACTUALLY BRING BIEL?
#5. The terms of the convertible promissory notes are horrible for BIEL. Less dilutive financing could have been put in place.
All of my comments are based on my own due diligence and are only my opinion. Please conduct your own due diligence and research before deciding whether to buy or sell any stock. My posts are for entertainment only.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM